Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
Bacterial Pneumonia
About this trial
This is an interventional treatment trial for Bacterial Pneumonia focused on measuring Pneumonia
Eligibility Criteria
Inclusion Criteria: Male or female subjects over 18 years of age. Bulgaria Only: Male or female subjects over 18 years of age and under 70 years of age. Subjects known or suspected to have acute hospital-acquired pneumonia. Exclusion Criteria: Presence of any of the following pulmonary conditions: cystic fibrosis; pulmonary malignancy (either primary or metastatic); known bronchial-obstructive or post obstructive pneumonia; pulmonary abscess; empyema; known or suspected active tuberculosis; bronchiectasis; sarcoidosis; known or suspected pulmonary infection caused by Pneumocystis carinii, mycobacteria, fungi, parasites, or viruses (Subjects with COPD are not excluded) Suspected or known Legionella infection Concurrent hemodialysis, hemofiltration, peritoneal dialysis, or plasmapheresis